-
Cardiome Pharma’s Xydalba treatment for ABSSSI available in UK
pharmaceutical-technology
June 27, 2017
Canadian pharmaceutical company Cardiome Pharma’s new intravenous (IV) antibiotic for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults, known as Xydalba (dalbavancin hydrochloride), has been made available in the UK.
-
UK among top performers in access to healthcare, says new report
europeanpharmaceuticalreview
June 26, 2017
The Global Access to Healthcare Index measures how healthcare systems across 60 countries are working to solve the most pressing healthcare needs…
-
DMD patients in the UK win early access to Santhera’s Raxone
pharmatimes
June 23, 2017
Santhera Pharmaceuticals’ Raxone has become the first drug for Duchenne Muscular Dystrophy (DMD) to join the UK’s Early Access to Medicines Scheme (EAMS).
-
BIA report shows UK on track to be world’s third global biotech cluster
europeanpharmaceuticalreview
June 20, 2017
A new report released by the UK BioIndustry Association (BIA) shows that the UK maintained its strong leadership position in European biotech funding last year and has the strongest pipeline in Europe for future drug development.
-
Merck's Glucophage® SR Receives Label Extension for Patients at High Risk of Type 2 Diabetes in the
en-cphi.cn
May 18, 2017
Merck, a leading science and technology company, today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has authorized Glucophage® SR (sustained release formulation; metformin)...
-
The Native Antigen Company expands into new development and production facilities in UK
pharmaasia
May 17, 2017
Expansion doubles manufacturing capacity, with new assay development facilities and new suite of services includes immunoassay development.
-
UK must prioritise $17bn medtech sector in face of Brexit, new report urges
pharmafile
May 04, 2017
A new report from the Institution of Mechanical Engineers (IME) has highlighted the threat Brexit poses...
-
CR UK, CRT Pioneer Fund and the NCI link on RAS
pharmatimes
April 19, 2017
Cancer Research UK and the Cancer Research Technology Pioneer Fund (CPF) are committing £2.5 million in collaboration...
-
UK heading towards GP crisis as 40% consider leaving
pharmafile
April 14, 2017
The University of Exeter has conducted a survey looking into GP morale in the south-west of the UK, and the results ...
-
Scotland first UK nation to routinely offer HIV PrEP
pharmatimes
April 12, 2017
Scotland will become the first UK nation to routinely offer HIV pre-exposure prophylaxis to all eligible patients after the...